trial · primary record
SHR-8068 + Adebrelimab + Bevacizumab
Hepatocellular Carcinoma
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 690 |
| Primary completion | 2031-09 |
| Primary endpoint | Progression-free survival (PFS) assessed by investigator |
| Registry ID | NCT07691762 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:33:57.782Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07691762
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.